What important information about GARDASIL should I know? You should continue to get routine cervical cancer screening. GARDASIL may not fully protect everyone who gets the vaccine. GARDASIL will not protect against HPV types that you already have. Who should not get GARDASIL? You should not get GARDASIL if you have, or have had: […]
Gardasil Safety: Post-marketing Experience
CONTRAINDICATIONS Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or after a previous dose of GARDASIL. WARNINGS AND PRECAUTIONS Syncope Because vaccinees may develop syncope, sometimes resulting in falling with injury, observation for minutes after administration is recommended. Syncope, sometimes associated with tonic-clonic movements and other seizure-like activity, has been reported following vaccination […]
Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females
This study is currently recruiting participants. Verified by Emory University, February 2010 Official Title Overcoming Barriers to Vaccination With GARDASIL in Underserved Girls and Adolescents Purpose African American adolescent females seeking treatment for STIs are an underserved population at increased risk for HPV infection. While GARDASIL is an effective preventive vaccine, vaccination rates are low. […]
Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients
This study is currently recruiting participants. Verified by University of Alberta, February 2010 Official Title Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients Purpose Human papillomavirus (HPV) affects a significant number of transplant patients. In women, human papillomavirus (HPV) causes genital warts, pre-cancerous areas of the cervix, and cervical cancer. […]
Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India
This study has been suspended. (Temporarily suspended: waiting for Indian Governement clearance ) Official Title Randomised Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India Purpose The primary study hypothesis is that a two-dose human papillomavirus (HPV) vaccine regimen would offer similar immunogenicity and protection as that of a three-dose regimen […]
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- Next Page »
